Literature DB >> 3000780

Interaction of human alpha-thrombin and gamma-thrombin with antithrombin III, protein C and thrombomodulin.

A Bezeaud, M H Denninger, M C Guillin.   

Abstract

Conversion of human alpha-thrombin to gamma-thrombin by limited proteolysis resulted in a decrease in the inactivation rate of the enzyme by antithrombin III. The second-order rate constants were similar but significantly different: 11 +/- 1.7 X 10(3) and 7 +/- 0.5 X 10(3) M-1 s-1 for alpha- and gamma-thrombin respectively. This difference is probably related to a slight change in reactivity of the catalytic site, rather than to a structural alteration of the recognition site for antithrombin III. The rate of protein C activation, measured in the absence of thrombomodulin, was greatly reduced by conversion of alpha-thrombin to gamma-thrombin. In addition, gamma-thrombin failed to displace alpha-thrombin from its complex with thrombomodulin, as demonstrated by measuring either the rate of protein C activation by thrombin-thrombomodulin, or the fibrinogen clotting activity of thrombin-thrombomodulin, in the presence of competing diisopropylphospho-thrombin. It is concluded that the recognition sites involved in protein-C-thrombin and thrombomodulin-thrombin interactions are both dramatically affected by the loss of peptide material occurring during the conversion of alpha-thrombin to gamma-thrombin and/or by the resulting conformational changes.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3000780     DOI: 10.1111/j.1432-1033.1985.tb09328.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  9 in total

1.  Ixolaris: a factor Xa heparin-binding exosite inhibitor.

Authors:  Robson Q Monteiro; Alireza R Rezaie; José M C Ribeiro; Ivo M B Francischetti
Journal:  Biochem J       Date:  2005-05-01       Impact factor: 3.857

2.  Probing the Dynamics of Clot-Bound Thrombin at Venous Shear Rates.

Authors:  Laura M Haynes; Thomas Orfeo; Kenneth G Mann; Stephen J Everse; Kathleen E Brummel-Ziedins
Journal:  Biophys J       Date:  2017-04-25       Impact factor: 4.033

3.  An acquired antithrombin autoantibody directed toward the catalytic center of the enzyme.

Authors:  P Sié; A Bezeaud; D Dupouy; G Archipoff; J M Freyssinet; J M Dugoujon; G Serre; M C Guillin; B Boneu
Journal:  J Clin Invest       Date:  1991-07       Impact factor: 14.808

4.  Characterization of bothrojaracin interaction with human prothrombin.

Authors:  R Q Monteiro; P E Bock; M L Bianconi; R B Zingali
Journal:  Protein Sci       Date:  2001-09       Impact factor: 6.725

5.  Activation of factor XI by products of prothrombin activation.

Authors:  Anton Matafonov; Suryakala Sarilla; Mao-fu Sun; John P Sheehan; Vladimir Serebrov; Ingrid M Verhamme; David Gailani
Journal:  Blood       Date:  2011-04-28       Impact factor: 22.113

6.  Thrombin interaction with a recombinant N-terminal extracellular domain of the thrombin receptor in an acellular system.

Authors:  M C Bouton; M Jandrot-Perrus; S Moog; J P Cazenave; M C Guillin; F Lanza
Journal:  Biochem J       Date:  1995-01-15       Impact factor: 3.857

7.  Increased expression of protease nexin-1 in fibroblasts during idiopathic pulmonary fibrosis regulates thrombin activity and fibronectin expression.

Authors:  Déborah François; Laurence Venisse; Joëlle Marchal-Somme; Martine Jandrot-Perrus; Bruno Crestani; Véronique Arocas; Marie-Christine Bouton
Journal:  Lab Invest       Date:  2014-09-08       Impact factor: 5.662

8.  Interaction of thrombin with antithrombin, heparin cofactor II, and protein C inhibitor.

Authors:  H C Whinna; F C Church
Journal:  J Protein Chem       Date:  1993-12

9.  Collagen can selectively trigger a platelet secretory phenotype via glycoprotein VI.

Authors:  Véronique Ollivier; Varouna Syvannarath; Angèle Gros; Amena Butt; Stéphane Loyau; Martine Jandrot-Perrus; Benoît Ho-Tin-Noé
Journal:  PLoS One       Date:  2014-08-12       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.